285 related articles for article (PubMed ID: 7749926)
21. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
Mast AE; Enghild JJ; Pizzo SV; Salvesen G
Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
[TBL] [Abstract][Full Text] [Related]
22. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.
Gettins PG; Olson ST
Biochem J; 2016 Aug; 473(15):2273-93. PubMed ID: 27470592
[TBL] [Abstract][Full Text] [Related]
23. Antithrombin and its deficiency states.
Lane DA; Olds RR; Thein SL
Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory conformation of the reactive loop of alpha 1-antitrypsin.
Elliott PR; Lomas DA; Carrell RW; Abrahams JP
Nat Struct Biol; 1996 Aug; 3(8):676-81. PubMed ID: 8756325
[TBL] [Abstract][Full Text] [Related]
25. The 1.5 A crystal structure of a prokaryote serpin: controlling conformational change in a heated environment.
Irving JA; Cabrita LD; Rossjohn J; Pike RN; Bottomley SP; Whisstock JC
Structure; 2003 Apr; 11(4):387-97. PubMed ID: 12679017
[TBL] [Abstract][Full Text] [Related]
26. Dysfunctional variants and the structural biology of the serpins.
Carrell R; Lomas D; Stein P; Whisstock J
Adv Exp Med Biol; 1997; 425():207-22. PubMed ID: 9433503
[No Abstract] [Full Text] [Related]
27. A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu).
Frangi D; Aulak KS; Cicardi M; Harrison RA; Davis AE
FEBS Lett; 1992 Apr; 301(1):34-6. PubMed ID: 1451784
[TBL] [Abstract][Full Text] [Related]
28. Understanding the specificity of serpin-protease complexes through interface analysis.
Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
[TBL] [Abstract][Full Text] [Related]
29. The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.
Simonovic I; Patston PA
Biochim Biophys Acta; 2000 Aug; 1481(1):97-102. PubMed ID: 11004579
[TBL] [Abstract][Full Text] [Related]
30. Hydrodynamic data show that C1- inhibitor of complement forms compact complexes with C1-r and C1-s.
Perkins SJ
FEBS Lett; 1990 Oct; 271(1-2):89-92. PubMed ID: 2226818
[TBL] [Abstract][Full Text] [Related]
31. Alpha1-antitrypsin deficiency--a model for conformational diseases.
Carrell RW; Lomas DA
N Engl J Med; 2002 Jan; 346(1):45-53. PubMed ID: 11778003
[No Abstract] [Full Text] [Related]
32. Three-dimensional structure and molecular modelling of C1- inhibitor.
Perkins SJ
Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
[TBL] [Abstract][Full Text] [Related]
33. Mammalian alpha 1-antitrypsins: comparative biochemistry and genetics of the major plasma serpin.
Patterson SD
Comp Biochem Physiol B; 1991; 100(3):439-54. PubMed ID: 1814672
[TBL] [Abstract][Full Text] [Related]
34. Substrate properties of C1 inhibitor Ma (alanine 434----glutamic acid). Genetic and structural evidence suggesting that the P12-region contains critical determinants of serine protease inhibitor/substrate status.
Skriver K; Wikoff WR; Patston PA; Tausk F; Schapira M; Kaplan AP; Bock SC
J Biol Chem; 1991 May; 266(14):9216-21. PubMed ID: 2026621
[TBL] [Abstract][Full Text] [Related]
35. Specificity and reactive loop length requirements for crmA inhibition of serine proteases.
Tesch LD; Raghavendra MP; Bedsted-Faarvang T; Gettins PG; Olson ST
Protein Sci; 2005 Feb; 14(2):533-42. PubMed ID: 15632287
[TBL] [Abstract][Full Text] [Related]
36. The reactive site loop of the serpin SCCA1 is essential for cysteine proteinase inhibition.
Schick C; Brömme D; Bartuski AJ; Uemura Y; Schechter NM; Silverman GA
Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13465-70. PubMed ID: 9811823
[TBL] [Abstract][Full Text] [Related]
37. The role of reactive-center loop mobility in the serpin inhibitory mechanism.
Lawrence DA
Adv Exp Med Biol; 1997; 425():99-108. PubMed ID: 9433493
[No Abstract] [Full Text] [Related]
38. Homozygous deficiency of heparin cofactor II: relevance of P17 glutamate residue in serpins, relationship with conformational diseases, and role in thrombosis.
Corral J; Aznar J; Gonzalez-Conejero R; Villa P; Miñano A; Vayá A; Carrell RW; Huntington JA; Vicente V
Circulation; 2004 Sep; 110(10):1303-7. PubMed ID: 15337701
[TBL] [Abstract][Full Text] [Related]
39. Molecular mousetraps and the serpinopathies.
Lomas DA; Belorgey D; Mallya M; Miranda E; Kinghorn KJ; Sharp LK; Phillips RL; Page R; Robertson AS; Crowther DC
Biochem Soc Trans; 2005 Apr; 33(Pt 2):321-30. PubMed ID: 15787598
[TBL] [Abstract][Full Text] [Related]
40. Alpha-1-antitrypsin deficiency, the serpinopathies and conformational disease.
Parmar JS; Lomas DA
J R Coll Physicians Lond; 2000; 34(3):295-300. PubMed ID: 10904927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
